Friday, March 05, 2021 11:01:20 AM
Re: Form Submission - Contact - Stock price
I would think with all the Press releases and milestones achieved that it’s very clear that the company is working toward revenues- again as I spelled out in my letter to shareholders, the additions made to the team - actual live human beings, a facility for building systems, patents etc etc.
For this to be a “scam” as you put it- I’d have to be the dumbest person ever to create a “scam” where I’m not taking a salary nor selling any of my shares.
How would that even make sense to anyone?
I’m executing the business plan as spelled out in the roadmap called “shareholders letter” will there be challenges to overcome? Of course it’s called business.
Dennis M O’Leary
Chairman, CEO, CFO
DarkPulse Technologies Inc
T: 800.436.1436
D: 212.256.1086
--
Dennis M O’Leary
Chairman, CEO, CFO
DarkPulse Technologies Inc
T: 800.436.1436
D: 212.256.1086
Recent DPLS News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:56:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 07:14:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/18/2023 09:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:16:05 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/07/2023 09:29:36 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 09:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 07:51:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/22/2023 08:41:26 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/31/2023 09:19:17 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:32:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 06:32:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 09:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 06:21:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM